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The Effects of Gorgonian Isis hippuris on Histologic Grade Score of
Adenocarcinoma Mammae Tissue in C3H Mice Strain
Anisatusholihah1, Neni Susilaningsih2
ABSTRACT
Background: Breast cancer is the most common cancer in women worldwide.
Gorgonian Isis hippuris is marine organism which its secondary metabolits
compounds was predicted to have a role in cytotoxic activity that can be
developed to be anticancer. In-vitro research proved anticancer activity of Isis
hippuris. The aim of this study was to find out the effects of Gorgonian Isis
hippuris extract in graded doses on histologic grade score of adenocarcinoma
mammae tissue in C3H mice strain.
Methods: This experimental study utilized post test only control group design.
Twenty C3H mice strain were divided into 4 groups. Treatment groups (P1, P2,
and P3) received 500 mg of food pellets that contained 0.15 mg; 1.5 mg; and 15
mg of Isis hippuris extract. The control group (C) received no treatment.
Treatment was routinely done for 3 weeks. Then all groups were inoculated with
adenocarcinoma mammae and the treatment were continued. After another three
weeks, all mice were terminated and operated to remove their tumors. Histologic
grade score of adenocarcinoma mammae tissues were observed and scored
according to Elston and Ellis modification of the Scarff-Bloom-Richardson.
Results: The highest mean of histologic grades score of adenocarcinoma
mammae was 5.32 (SD 0.61) on C group while the lowest was 4.02 (SD 0.08) on
P3 group. Kruskal Wallis Test presented significant differences with p value was
0.008 (p<0.05). There were significant differences between C group and P1 group
(p=0.009), C group and P2 group (0.012); and also C group and P3 group
(p=0.009). However, there were no significant differences among treatment
groups.
Conclusion: Gorgonian Isis hippuris extract could decrease histologic grade score
of adenocarcinoma mammae tissue in C3H strain mice. Gorgonian Isis hippuris
extract could decrease histologic grade score of adenocarcinoma mammae tissue
in C3H mice at any doses were used in this experiment.
Keyword: Gorgonian Isis hippuris, Histologic Grade Score, Adenocarcinoma
Mammae
1Student of Faculty of Medicine, Diponegoro University, Semarang
2Lecturer of Histology Department, Diponegoro University, Semarang
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Pengaruh Pemberian Ekstrak Gorgonian Isis hippuris Terhadap Skor
Derajat Histologis Jaringan Adenokarsinoma Mammae Mencit C3H
Anisatusholihah1, Neni Susilaningsih2
ABSTRAK
Latar Belakang: Kanker payudara merupakan keganasan yang paling sering
dialami wanita di dunia. Gorgonian Isis hippuris merupakan biota laut dengan
kandungan senyawa metabolit sekunder yang memiliki sifat toksisitas dan
berpotensi sebagai zat antikanker. Penelitian in-vitro telah membuktikan aktivitas
antikanker dari Isis hippuris. Penelitian ini bertujuan untuk mengetahui pengaruh
pemberian pemberian ekstrak Gorgonian Isis hippuris terhadap skor derajat
histologis jaringan adenokarsinoma mammae mencit C3H.
Metode: Penelitian eksperimental ini menggunakan Post Test Only Control
Group Design. Dua puluh ekor mencit strain C3H dibagi menjadi 4 kelompok.
Kelompok perlakuan (P1, P2, dan P3) diberi pakan perlakuan sebanyak 500 mg
yang masing-masing mengandung ekstrak Isis hippuris sebanyak 0,15; 1,5; dan 15
mg. Kelompok kontrol (C) hanya menerima pakan standar. Perlakuan dilakukan
selama tiga minggu. Kemudian seluruh mencit diinokulasi sel kanker dan
perlakuan dilanjutkan kembali selama tiga minggu berikutnya. Skor derajat
histologis adenokarsinoma mammae dinilai dengan metode Elston and Ellis
modification of the Scarff-Bloom-Richardson.
Hasil: Nilai rerata tertingggi skor derajat histologis adenokarsinoma mammae
adalah 5.32 (SD 0.61) pada kelompok kontrol (C) sedangkan yang terendah 4.02
(SD 0.08) pada kelompok perlakuan P3. Uji Kruskal Wallis menunjukkan
perbedaan bermakna dengan nilai p=0.008 (p<0.005). Terdapat perbedaan
bermakna antara kelompok C dan P1 (p=0.009); antara C dan P2 (p=0.012); dan
antara C dan P3 (p=0.009). Dalam kelompok perlakuan tidak terdapat perbedaan
bermakna antar masing-masing kelompok dosis bertingkat.
Kesimpulan: Ekstrak Gorgonian Isis hippuris dapat menurunkan skor derajat
histologis jaringan adenokarsinoma mammae mencit C3H. Semua dosis yang
digunakan dalam penelitian ini dapat menurunkan skor derajat histologis.
Kata Kunci: Gorgonian Isis hippuris, skor derajat histologis, adenokarsinoma
mammae.
1)Mahasiswa Fakultas Kedokteran Universitas Diponegoro
2)Staf Pengajar Bagian Histologi Fakultas Kedokteran Universitas Diponegoro
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CHAPTER 1
INTRODUCTION
1.1. Background
Breast cancers which begin in breast tissue, are a group of diseases that
cause cells in the body to change and grow out of control.1-2 Breast is the most
common site of cancer in women.3-6 In Indonesia from 2004 to 2006, breast
cancer is the most common type of cancer followed by cervical cancer.7
Chemotherapy has become one of the important components for breast cancer
therapy. Since there are high costs, unsatisfying, and multi-drug resistant for
several types of breast cancers, finding alternative anticancer becomes
necessary.1-2
The discovery of Indonesia marine organisms biomedical potency gave
an alternative in development of cancer therapy.8-9 One of Indonesia marine
potency sources that is potential enough to be explored is Gorgonian Isis
hippuris.10-12 Gorgonian Isis hippuris has many secondary metabolites
compound including polyoxygenated steroids, sesquiterpene, hydrocarbon,
phenol and fatty acids.12-21 Those compounds were predicted to have a role in
cytotoxic activity which can be developed to be anticancer.10-21
Previous studies demonstrated the effect of Isis hippuris extract againsts
the growth of leukemia cell line L1210.10 Besides, in vivo toxicity
experiments were done in graded doses based on the half maximum inhibitory
concentration (IC50) values.22 This in vivo experiment about anticancer
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activity of Gorgonian Isis hippuris extract was a continuation of those
researches.
Cancer cell has uncoordinated cell growth and proliferative activity.23
Histologic grade in breast cancer essentially describes proliferation and
differentiation in breast cancer.24 Pathologists closely observe three features
when determining grade of breast cancer: tubule formation, nuclear
pleomorphism, and mitotic count. Within the last decades, histologic grade
has become widely accepted as a powerful indicator of prognosis in breast
cancer.25-26
1.2. Research Problem
What are the effects of Gorgonian Isis hippuris extract on histologic
grade score of adenocarcinoma mammae tissue in C3H mice strain?
1.3. Research Purposes
1.3.1. General Purpose
To find out the effects of Gorgonian Isis hippuris extract on
histologic grade score of adenocarcinoma mammae tissue in C3H
mice strain.
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1.3.2. Specific Purposes
a. To compare the effects of Gorgonian Isis hippuris extract on
histologic grade score of adenocarcinoma mammae tissue in C3H
strain mice between treatment groups and control group.
b. To determine the most effective dose among three experimented
doses of Gorgonian Isis hippuris extract.
1.4. Research Benefits
a. Providing information about the effects of Gorgonian Isis hippuris on
breast cancer.
b. As a basic development of adenocarcinoma mammae alternative therapy.
c. As a preliminary study for further research and study about medical use of
Gorgonian Isis hippuris.
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CHAPTER 2
LITERATUR REVIEW
2.1. Gorgonian Isis hippuris
Gorgonian is the most familiar ordo of the octocorallians sub-class. Its
class is Anthozoa and it is included in Cnidaria (coelenterata) phylum.
Gorgonian colonies can take the form of whips, fans or bushy shrub-like
colonies. They are often brightly colored and common in shallow water.
Gorgonian Isis hippuris is soft coral, commonly called “sea fans” because the
colony has many branches and it grows as fan. These marine invertebrates
animals have an axial skeleton composed of an organic substance called
gorgonin (a tanned collagen) and the thick layer, coenenchyme, protects its
frame.27-28
Gorgonians are common and conspicuous members of reefs’ faunas,
which can be found in Andamas Sea, Philipina, Taiwan, Indonesia, Papua
Nugini, and Ryukyu Archipelago. In Indonesia, based on research, these
marine organisms can be found in some regions, such as Jepara Sea,
Karimunjawa Archipelago, Krakatau Archipelago, Makassar Sea, and Flores
Sea.10
Gorgonian Isis hippuris has many secondary metabolites compounds and
it was predicted that Gorgonian Isis hippuris has a role in their defense
mechanism so it also has toxicity.10-11 High cytotoxic effect of Gorgonian Isis
hippuris can be developed to be anticancer. Analysis results profound that
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Gorgonian Isis hippuris extract contains at least 18 compounds which many
of them are hydrocarbon, phenol and fatty acid.10-11,16-18
Previous studies on Isis hippuris resulted the isolation of a series novel
metabolites, including polyoxygenated steroids and suberosane-type
sesquiterpene.16-18 Polyoxygenated steroids which are isolated from
Gorgonian Isis hippuris have been determined based on its side chain into
hippurins or hippuristanols having a spiroketal, gorgosterol or gorgosteroid
possessing a cyclopropane, hippuristerones and hippuristerol containing a
3-keto function.16-19 Some hippuristanols and suberosane-type sesquiterpene
were reported to have significant cytotoxicity againts several cancer cell
line.19
Five new suberosane sesquiterpenes: suberosenol A, suberosenol B,
suberasanone, suberosenol A acetat, and suberosenol B acetat, along with the
known sesquiterpene subergorgic acid, have been isolated from the
Gorgonian Isis hippuris. Suberosanone exhibited potent cytoyoxicity toward
several cancer cell lines. Suberosenol A, suberasanone, and suberosenol B
acetat were found to exhibit potent cytotoxicity toward P-388, A549 (human
lung adenocarcinoma), and HT-29 (human collon adenocarcinoma) cancer
cell lines.13,16
Hippuristanols are steroids with spiroketal ring in the side chain. Two
bioactive sterols, hippuristanol and 2a¹ 7a¹-dihydroxy hippuristanol showed
cytotoxicity againts fibrosarcoma respectively. Hippuristanol was also
reported to be active againts P-388 cell (lymphocytic leukemia in mice).12
Create PDF with GO2PDF for free, if you wish to remove this line, click here to buy Virtual PDF Printer
Hippuristanols collected showed the ability to slow down, possibly prevent
virus replication and may promise a cancer treatment. Hippuristanol is an
inhibitor of eukaryotic translation initiation. It prevents eIF4A (eukaryotic
initiation factor 4A) protein from binding to mRNA, which carries the code to
make proteins from DNA to specific sites of protein synthesis in the cell.29
Gorgosterols, hippuristerol, and hippuristerones are other steroids that
have been isolated from Gorgonian Isis hippuris which reported also have
cytotoxicity againts cancer cell line although not significant. Recent studies
resulted the isolation of novel hippuristerones A-L, hippuristerol A-F, and
identified gorgosterol. Another bioactive compound that have been isolated
from Gorgonian Isis hippuris is gorgost-5-en-3ßœ,7aœ,12ßœ-triol-11aœ,15S-
diasetat, showed selective inhibition againts KB-C2 cell line (multidrugs
resistant cancer cell).14-15,20
2.2. Mammary Glands
The mammary glands in the breasts are parts of reproduction system in
women. The mammary glands are placed in the subcutaneous tissue overlying
the pectoralis major and minor muscles. Female breast extends transversely
from lateral border of sternum to the midaxillary line and vertically from
second through sixth ribs. Breasts size and shape are determined by genetic,
ethnic, and dietary factors. Inactive female breasts weight are 150-200 grams
and active female breasts weight are 400-500 grams.30
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The arterial supply of breast derives from lateral thoracic arteries,
thoracoabdominal arteries, posterior intercostal arteries, medial mammary
arteries and anterior intercostal arteries. The venous drainages of breast
mainly flow to the axillary vein, and some drainages flow to the internal
thoracic vein. Lymph passes from the nipple, areola, and lobules of the gland
to the subareolar lymphatic plexus. Most lymph from the periphery quadrant
drains to the axillary lymph nodes, while most lymph from central quadrant
drains to parasternal lymph nodes or to opposite breast. The nerve of breast
derived from anterior and lateral cutaneous branches of the forth until sixth
intercostal nerves. Those are the vasculatures and nerves of the breast.31
The mammary glands are compound tubuloalveolar glands that consist of
15 to 20 lobes radiating out from the nipple and are separated from each other
by adipose and collagenous connective tissue. The lactiferous ducts give rise
to buds that form lobules of glandular tissue and converge toward the niple.
These ducts, 2 - 4,5cm long, emerge independently in the nipple, which has
15-25 openings, each of them is about 0,5mm in diameter. Deep to areola,
each duct has dilated portion, the lactiferous sinus, which is a small droplet of
milk accumulate in the nursing mother.32
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2.3. Adenocarcinoma Mammae
2.3.1. Epidemiology and Risk Factor
Breast cancer is the most common cancer in women worldwide.3-6
The incidence of breast cancer continuous to increase, but mortality
has stayed the same. It will be the number one of four leading causes
projected of death globally in 2030.33
Indonesia’s 2007 health profile reported that breast cancer is the
most common type of cancer followed by cervical cancer.7 Estimation
of breast cancer incidence of Indonesia is 26 per 100.000 women.4 In
Central Java, based on hospital report programme, breast cancer is the
most common cancer about 3.593 cases (43,91% from 8.182 cancer
cases). The most cases occur in Semarang approximately 1.205 cases
(33,53%).34
The primary risk factors that have been identified are sex, family
history, genetics, age, previous medical history, hormones, a high-fat
diet, alcohol intake, obesity, and environmental factors such as
tobacco use and radiation.1-2
According to histologic representation, breast cancer can be
classified as non invasive breast cancers or carcinoma in situ and
invasive (infiltrative) breast cancers.25 These are incidences of
histologic diagnosis:
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Table 1. Incidences of histologic diagnosis25
Type Incidence
In Situ Carcinoma 15%-30%
Ductal carcinoma in situ 80%
Lobular carcinoma in situ 20%
Invasive carcinoma 70%-85%
Ductal carcinoma 59%
Lobular carcinoma 4%
Tubular/cribriform carcinoma 4%
Mucinous carcinoma 7%
Medullary carcinoma 8%
intracystic carcinoma
other diagnoses
5%
13%
2.3.2. Sign, Symptom and Treatment
Early-stage breast cancer typically produces no symptom when
the tumor is small and most treatable. When breast cancer has grown
to a size that can be felt, the most common physical sign is a painless
mass. Few common signs and symptoms appear, include breast pain
or heaviness and persistent changes to the breast, such as thickening,
swelling, redness, and nipple abnormalities such as spontaneous
discharge, erosion, inversion, or tenderness.1-2
Many factors which are considered in making an accurate
diagnosis and treatment decisions are the type of breast cancer, size of
tumor, stage, hormone receptor status, lymph node involvement, and
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the tumor grade. A pathologist will take a sample of tissue from
tumor, and examine it under a microscope. Tumor cells that look most
like normal cells are given a low grade, while those that look the most
abnormal are given a high grade. High-grade tumors are fast-growing,
spreading (metastatic), and aggressive. Knowing tumor grade helps a
doctor to decide the best treatments.35
Taking into account tumor size, stage, and hormone receptor
status, lymph node involvement, and the tumor grade, treatment may
involve lumpectomy or mastectomy with removal of some of the
axillar lymph nodes (to obtain accurate information on stage of
disease). It may also involve radiation therapy, chemotherapy (before
or after surgery), hormone therapy (tamoxifen, aromatase inhibitors),
or targeted biologic therapy. Targeted therapy with trastuzumab
(Herceptin®) or lapatinib (Tykerb®) is sometimes used in women
whose cancer tests positive for HER2/neu. Two or more methods are
often used in combination. Numerous studies have shown that long-
term survival rates after lumpectomy plus radiation therapy are similar
to survival rates after mastectomy for women whose cancer has not
spread to the skin, chest wall, or distant organs. Tumor grade can be
used to know the spreading.1-2,6
Cancer medication in advanced stage is not only very difficult
but also the result is very unsatisfied. Medication for advanced stage
cancer patient needs sophisticated technology, skills, and high costs.
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So, alternative therapy which is cheaper than that and available in
abundant amount is very necessary.1-2
2.4. Carcinogenesis
Carcinogenesis involves damage-induced genetic mutations that produce
cancers.38 Many of the most powerful biological regulators of cell growth and
proliferation are encoded by unstable mRNAs, which are targeted for rapid
degradation by the cell. The loss of rapid degradation of these growth-
promoting mRNAs can result in oncogenic transformation of the cell.37
There are several ways in which translational control is relevant to
cancer. Firstly, the effciency of expression of key proteins involved in cell
growth regulation, proliferation or cell death may be controlled at the
translational level by changes in the activity of components of the protein
synthesis machinery.38-39 Secondly, mutations that lead to changes in the
structure of individual mRNA species may alter the rates at which the
proteins encoded by these mRNAs are produced.37,39 Thirdly, disruptions in
the regulation of signalling pathways that result in a loss of constraint on the
synthesis of growth-promoting proteins (or impair the synthesis of growth-
inhibitory or pro-apoptotic proteins) may alter the balance of production of
key cellular components. Finally, infection of cells with tumour-associated
viruses can result in interference with normal cellular controls on translation
that may contribute to the transformed phenotype.39
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Carcinogenic agents include mutagenic carcinogens, non-mutagenic
carcinogens, irradiation, viruses (tumorigenic viruses), transforming
retroviruses and DNA tumor viruses encode oncogenes, and genetic
predisposition.38 Carcinogenesis is typically resulted from a series of
mutations that affect regulation of proliferation. These are the process of
carcinogenesis; (1) inactivation of a tumor suppressor gene (TSG) results in
cell proliferation, (2) mutation inactivates a DNA repair gene, (3) mutation of
a proto-oncogene generates an oncogene, (4) mutation inactivates more
cancer suppressor genes, resulting in cancerous proliferation.38
These are mutations lead to characteristics of cancer cells: 37-38
a. Loss of normal cell differentiation or inability to undergo normal cell death
(apoptosis).
In normal condition, cell divides and differentiates, passing through
many steps. Growth factors that are known to stimulate transitions are
indicated. Aberrant differentiation due to cancer can be caused by malignant
cells that arise at any stage during the process of differentiation or cells are
normal but they differentiate into different kind of cells.
b. Unregulated cell proliferation.
Cell proliferation is controlled by growth factors that bind to receptors on
the cell surface that connect to signaling molecules (signal transduction
pathway) that convey message from receptor to the nucleus where
transcription factors bind to DNA, turning on or off the production of proteins
that cause cells to continue dividing. Mutations in any of the genes encoding
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these types of proteins can affect proliferation and many examples have been
found in cancer cells. For example, several mutations affecting different
proteins that regulate one part of the cell cycle (G1 to S phase) have been
consistently seen in many tumors.
c. Genomic instability.
Cancer cells exhibit genomic instability. Chromosomal rearrangements
and duplications are often seen in the karyotype of cancer cells. Cells
normally will stop in the cell cycle if DNA is damaged. Several proteins have
been identified that act to halt the cell cycle until DNA damage is repaired.
2.5. Immune Responses to Tumors
Tumors express antigens that are recognized by the immune system. The
effector mechanisms of both cell-mediated immunity and humoral immunity
have been shown to kill tumor cell in vitro. Effector of cell-mediated
immunity are T-cells, Natural Killer cells, and Macrophages. Whereas cell-
mediated immunity are more dominant, our body also produce antibody to
respond tumor antigen.38
The T-cells response is the most important host response for the control
of growth of antigenic tumor cells, it responsible for both direct killing of
tumor cells and the activation of other component of the immune system. The
principal mechanism of tumor immunity is killing tumor cells by CD8+ CTLs.
Cytotoxic T Lymphocytes may perform a surveillance function by
recognizing and killing potentially malignant cells hat express peptides
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derived from mutant cellular proteins or oncogenic viral proteins and
presented as foreign peptides in association with class I Major
Histocompatibility Complex (MHC) molecules. CTLs are distinguished by
expressing the CD8+ coreceptor on their surfaces. CD8+ cells responses
specific for tumor antigens may require cross presentation of the tumor
antigens by Antigen Presenting Cells (APCs). Most tumor cells are not
derived from APCs so stimulation of helper T cells is needed to promote the
differentiation of CD8+ T cells. The second major class of T-cells, the T-
helper cells, express a coreceptor called CD4, which binds to class II MHC
molecules. CD4 strengthens the interaction between T-cell receptor and the
antigenic complex on Antigen Presenting Cells (APCs). When antigenic
triggering, these T-cells further secrete cytokines, such as tumor necrosis
factor (TNF) and interferon-?)(IFN-?), that can increase tumor cell class I
MHC expression and sensitivity to lysis by CTLs. IFN-?pmay also activate
macrophages to kill tumor cells.38,40
NK cells can kill a wide range of tumor targets in vitro. The cytolytic
potential of NK cells is largely contained by off signals delivered via families
of inhibitory receptors that bind to class I molecules on potential target.
Cytolysis of NK cells is mediated by the release of cytotoxic factors and the
use of perforins to puncture holes in the target cell membrane.40
Macrophages are important in tumor immunity as antigen presenting
cells to stimulate the immune response to mediate tumor lysis. Their
mechanisms include the release of lysosomal enzymes, cytokine TNF,
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reactive oxygen intermediate, and nitric oxide. Macrophages are activated by
Macrophages Activating Factors (MAF) which are secreted by T-cells.40
Tumor-bearing hosts may produce antibodies against various tumor
antigens. Antibodies may kill tumor cells by activating complement or by
antibody dependent cell-mediated cytotoxicity. Complement-antibody bind to
the tumor cell membrane and promote attachment of complement components
that create pores in the membrane, resulting cell disruption. An alternative
mechanism is Antibody Dependent Cell-mediated Citotoxicity (ADCC), in
which antibodies, form an intercellular bridge by binding via the variable
region to a specific determinan on target cell.38
2.6. Histologic Grade
Within the last decades, histologic grade has become widely accepted as
a powerful indicator of prognosis in breast cancer. Pathologists closely
observe three features when determining a cancer grade: the frequency of cell
mitosis (rate of cell division), tubule formation (percentage of cancer
composed of tubular structures), and nuclear pleomorphism (change in cell
size and uniformity). Each of these features is assigned a score ranging from
1 to 3 (1 indicates slower cell growth and 3 indicates faster cell growth). The
scores of each of the cells’ features are then added together for a final sum
that will be ranged from 3 to 9. The Scarff-Bloom-Richardson (SBR) system
is the most common type of cancer grade system used today.25-26
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In Europe, the Elston-Ellis modification of the SBR grading system
(Nottingham grading system) is preferred and is becoming increasingly
popular in the US. This modification provides somewhat more objective
criteria for the three component elements of grading and specifically
addresses mitosis counting in a more rigorous fashion. For example
hyperchromatic nuclear and apoptotic cells which are counted in the original
SBR system are excluded in the Elston-Ellis modification and the area being
assessed is specifically defined in square millimeters. These modifications
have enhanced reproducibility of grading among pathologists and to a
considerable extent have fostered acceptance of grading by clinicians.25-26
Table 2. Histologic grade score of adenocarcinoma mammae according to
Elston and Ellis modification of the Scarff-Bloom-Richardson25-26
Score
Appearance
1 2 3
Tubule formation >75% 10-75% <10%
Nuclear
pleomorphism
Small, uniform
cell
Moderate increase
in size and
variation
Marked variation
Mitosis count 0-7 8-14 >15
The following is total score that indicates the grade of adenocarcinoma
mammae:
Grade I (well differentiated) : 3-5
GradeII (moderate differentiated) : 6-7
Grade III (poorly differentiated) : 8-9
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Histologic grade has been shown to be useful predictors of prognosis for
patients stratified by stage of diseases. Increasing tumor grade has been
associated with several factors that are related to an increased risk for
recurrence after conservation therapy. In patients with relatively favorable
stage I carcinomas treated by lumpectomy without radiotherapy, the tumor
recurred sooner and with greater frequency in high grade carcinomas.26
Table 3. Histologic grade of adenocarcinoma mammae according to
Scarff-Bloom-Richardson and survival rates26
Grades Description Score 5 yr.
survival
7 yr.
survival
Grade 1
(lowest)
Well-differentiated breast
cells;
cells generally appear normal
and are not growing rapidly;
cancer arranged in small
tubules.
3,4,5 95% 90%
Grade 2 Moderately-differentiated
breast cells;
have characteristics between
Grade 1 and Grade 3 tumors.
6,7 75% 63%
Grade 3
(highest)
Poorly differentiated breast
cells;
Cells do not appear normal
and tend to grow and spread
more aggressively.
8,9 50% 45%
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CHAPTER 3
THEORITICAL FRAMEWORK,
CONCEPTUAL FRAMEWORK, AND HYPOTHESIS
3.1. Theoritical Framework
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fas ligan TNF
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3.2. Conceptual Framework
3.3. Hypothesis
a. Gorgonian Isis hippuris extract have effects to decrease histologic grade
score of adenocarcinoma mammae tissue in C3H mice strain.
b. The most effective dose among three experimented doses of Gorgonian
Isis hippuris extract is 15 mg (the highest dose).
Gorgonian Isis
hippuris extract
Histologic grade
score of
adenocarcinoma
mammae
Adenocarcinoma
mammae tissue of
C3H mice
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